Sign in

    Cecilia Gong

    Vice President and Equity Research Analyst at JPMorgan Chase & Co.

    Cecilia Gong is a Vice President and Equity Research Analyst at JPMorgan Chase & Co., specializing in U.S. integrated oil and gas sector research. She covers major industry players such as Chevron, ExxonMobil, and ConocoPhillips, delivering actionable investment insights, and is recognized for her detailed fundamental analysis and stock recommendations. Cecilia began her career at JPMorgan after earning her undergraduate degree in economics, advancing from associate to her current VP role while earning accolades for her analytical rigor and strong client service. She is FINRA-registered with Series 7, 63, and 86/87 licenses, and has consistently received positive feedback from institutional investors for her research quality and thematic sector reports.

    Cecilia Gong's questions to TransMedics Group (TMDX) leadership

    Cecilia Gong's questions to TransMedics Group (TMDX) leadership • Q3 2024

    Question

    Cecilia Gong of JPMorgan Chase & Co. asked about the recovery seen in Q4, the confidence in reiterating guidance, and the reasons for the sequential decline in heart transplant revenue, specifically questioning the potential impact of NRP competition.

    Answer

    CEO Waleed Hassanein confirmed that market dynamics began to normalize in early October, supporting the reiterated guidance. He categorically denied any impact from competitive technologies like NRP on the heart volume decline, attributing it directly to a national volume downturn and noting TransMedics' DCD heart transplant share is approximately 70% and has grown.

    Ask Fintool Equity Research AI